Article Information
History
- March 23, 2020.
Article Versions
- You are currently viewing Version 1 of this article (March 23, 2020 - 06:20).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sidhant Chopra*,1,
- Alex Fornito1,*,†,
- Shona M. Francey2,
- Brian O’Donoghue3,
- Vanessa Cropley4,
- Barnaby Nelson3,
- Jessica Graham2,
- Lara Baldwin2,
- Steven Tahtalian4,
- Hok Pan Yuen3,
- Kelly Allott3,
- Mario Alvarez-Jimenez3,
- Susy Harrigan5,
- Kristina Sabaroedin1,
- Christos Pantelis6,
- Stephen J Wood7 and
- Patrick McGorry3
- 1Monash University, Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging
- 2Orygen
- 3Orygen; The University of Melbourne, Centre for Youth Mental Health
- 4University of Melbourne; Melbourne Neuropsychiatry Centre
- 5University of Melbourne, Centre for Mental Health, Melbourne School of Global and Population Health
- 6University of Melbourne; Melbourne Neuropsychiatry Centre; The Florey Institute of Neuroscience and Mental Health
- 7Orygen; University of Melbourne; University of Birmingham, School of Psychology
- ↵†Corresponding Author:
Alex Fornito (alex.fornito{at}monash.edu)
↵* Authors contributed equally
Posted March 23, 2020.
Differentiating the Effect of Medication and Illness on Brain Volume Reductions in First-Episode Psychosis: A Longitudinal, Randomized, Triple-blind, Placebo-controlled MRI study
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos